<DOC>
	<DOCNO>NCT00683267</DOCNO>
	<brief_summary>Evaluate efficacy , safety tolerability single intraoperative dose 4975 patient undergoing total hip replacement</brief_summary>
	<brief_title>Efficacy Safety Study 4975 Patients Undergoing Total Hip Replacement</brief_title>
	<detailed_description>The purpose study evaluate efficacy , safety , tolerability single intraoperative dose 4975 patient undergo primary unilateral total hip arthroplasty</detailed_description>
	<mesh_term>Capsaicin</mesh_term>
	<criteria>Key Male female age 18 85 year American Society Anesthesiologists ( ASA ) status I , II , III Planning undergo unilateral THA In good health capable undergoing THA spinal block sedation anesthesia No additional plan surgery course trial Willing able complete study procedure pain scale communicate meaningfully English Key A body mass index great 40 Known bleed disorder take agent affect coagulation preoperatively A medical condition could adversely impact patient 's participation , safety , conduct study Diabetes mellitus know HbA1C &gt; 9.5 history prolong uncontrolled diabetes Previous hip arthroplasty hip Participated another clinical trial within 30 day plan hip surgery</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>May 2009</verification_date>
	<keyword>THA , Total hip arthroplasty , total hip replacement</keyword>
</DOC>